Skip to main content

Launch of User-Friendly Hematology Analyzers is the Best Way to Venture into the Market

The global hematology testing is perceived to be a market with high attractiveness, by the investors. Strong investments in this field aided by considerable research activities by both public and private sectors are expected to propel the growth of the market in the years that follow. In spite of having several favorable factors, investments into the market are being hindered by the slow adoption rate of expensive hematology testing devices in low income and middle-come countries of the world. The most promising way to venture into this market and gain measurable profits is through innovations and development of advanced, compact, accurate, and user-friendly hematology analyzers.

Sysmex Corporation, headquartered in Japan is catering to in-vitro diagnostics, offers wide range of hematology testing products ranging from hematology analyzers and flow cytometers to reagents, stains, controls, and calibrators. The huge product contribution of the company resulted in its market dominance in 2017 and 2018, with an overall good amount of the global market share in 2017 and 34.73% of the global market share in 2018. Following Sysmex Corporation, Abbott Laboratories was the second major contributor of the global market revenue, accounting for good rate of the total market share in 2017 and 2018, respectively.

Next to North America, Europe is the second leading contributor of the global hematology testing market. Increasing research and investments pertaining to the development technologically advanced hematology testing products coupled with significant support from both public and private sectors in terms of funding are the key driving factors for the growth of the hematology testing in Europe. Europe contributed to 23.00% of the market share in 2018. Within Europe, Germany is the leading country and Italy is expected to witness the highest CAGR during the forecast period between 2019 and 2029.



The global hematology testing market, by end user, is concentrated around hospitals, clinical testing laboratories, research institutions, and patient self-testing, among others. With the growing prevalence of blood-related disorders across the world, the need to develop advanced hematology tests is growing rapidly leading to vast technological advancement in the field of hematology.
Labels:

Comments

  1. Blog279995 March 2020 at 18:14

    According to Stanford Medical, It's indeed the one and ONLY reason women in this country get to live 10 years longer and weigh 42 pounds less than we do.

    (By the way, it really has NOTHING to do with genetics or some secret diet and EVERYTHING around "HOW" they eat.)

    P.S, I said "HOW", and not "what"...

    TAP this link to determine if this quick quiz can help you unlock your true weight loss possibility

    ReplyDelete

Post a Comment

Popular posts from this blog

Chatbots Increasing Efficiency in Healthcare Market

Chatbots are one of the prominent technologies currently being integrated into the healthcare system. The chatbots are not considered as the SaMD (software as medical device) as they do not participate in clinical decision-making process, rather, they act as the personal healthcare assistant as well as the trainer for its users. Click Here To Get Detailed Description of  Chatbots in Healthcare Market The usage of chatbots in the healthcare has gained popularity since 2013, when Babylon Health, the first healthcare chatbot company of the U.K. was launched. The company offered symptom checker chatbot and has started using the same chatbot as a health checker as well. The industry comprises the bot developers, platform providers, content providers, and the interface providers. Since there are no regulatory bodies such as FDA and MHRA directly governing the usage of chatbots, launching the chatbot is convenient for the developers. New start-ups are coming up wit...
2 comments
Read more

Wireless Charging Technology – Analyzing the Market Drivers and Restraints

Wireless charging technology eliminates the use of wires to power devices and enables a device to be charged automatically when placed near a transmitter. The wireless charging technology is however, not new in the world of technology, rather, has been in existence since the late 1800s. With the incorporation of the technology in smartphones, it has been experiencing a massive boost in popularity. Request the Sample @  https://bisresearch.com/requestsample?id=645&type=download According to the latest market intelligence report by BIS Research titled “ Global Wireless Charging Market - Analysis and Forecast (2018-2023) ,” the market was valued at $2.58 billion in 2017 and is projected to grow at a CAGR of 40.97%, during the forecast period and reach $20.97 billion by 2023.  The market is estimated to witness the highest growth in the Asia-Pacific (APAC) region during the forecast period (2018-2023). The wireless charging technology is not only limited to the sm...
1 comment
Read more

Neoantigens Vaccines Can Bridge the Treatment Gap by Training the Immune System to Recognize Tumor Cells

As per BIS Research analysis, the neoantigen cancer vaccine market is projected to reach $1826.1 million by 2030 from $227.1 million in 2023, at a CAGR of 34.69%. Growth in this market is expected to be driven by the ever-rising patient pool of different cancers and significant investment in research for development for cancer neoantigen vaccines to fill in the current treatment gaps. However, there are significant challenges that are restraining the market growth. These challenges include the high cost of therapy (personalized cancer vaccines), manufacturing complications, and lack of therapeutic biomarkers and assays. The market is still at the nascent phase with more than two-thirds of the neovaccines in the early stages of development. However, few neovaccines companies such as OSE Immunotherapeutics, Immunovative Therapeutics, Medigene, and Roche have positioned themselves to launch their neovaccines in the market within the upcoming years. That being said, the neovacc...
1 comment
Read more